Delisting of Vigmed – last day of trading 21 July 2017

Nasdaq Stockholm AB has approved Vigmed Holding AB's application regarding delisting the company's share from Nasdaq First North and has determined that the last day of trading in the Vigmed shares is 21 July 2017.

For more information
CEO Henrik Olsen, tel. +46 763-497 364
Board member Georg Heftberger, tel. +43 664 884 106 83

This information was submitted for publication, through the agency of the contact persons set out above, at 8:00 a.m. CET on 7 July 2017.

Vigmed is a Swedish medical technology company whose mission is to eliminate needlestick injuries and the associated risk of cross infections with blood-borne infectious diseases by offering the market unique needle-protected products. Vigmed is headquartered in Helsingborg, Sweden. Vigmed’s share is traded on Nasdaq First North in Stockholm (ticker VIG). Remium Nordic AB is the Company’s Certified Advisor. Additional information about the company can be found on Vigmed’s website:   www.vigmed.com/investor  

Tags:

About Us

Vigmed is a Swedish medical technology company whose mission is to eliminate needlestick injuries by offering the market unique needle-protected products. Vigmed is headquartered in Helsingborg, Sweden. Vigmed’s share is traded on NASDAQ OMX First North in Stockholm (ticker VIG) and the company has approximately 5 600 shareholders. Remium Nordic AB is the Company’s Certified Advisor. Additional information can be found on Vigmed’s home page: www.vigmed.com

Subscribe

Documents & Links